Iron chelators as therapeutic agents for the treatment of cancer

This publication has 97 references indexed in Scilit:

• Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines
  Carcinogenesis: Integrative Cancer Research, 2000
• Pharmacokinetics and Pharmacodynamics of Hydroxyurea
  Clinical Pharmacokinetics, 1998
• The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
  Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1997
• Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: Preliminary results
  European Journal Of Cancer, 1995
• Iron chelators of the pyridoxal isonicotinoyl hydrazone class
  BioMetals, 1989
• The mechanisms of iron uptake by fetal rat hepatocytes in culture
  Hepatology, 1986
• Continual presence of oxygen and iron required for mammalian ribonucleotide reduction: Possible regulation mechanism
  Biochemical and Biophysical Research Communications, 1983
• Role of ribonucleotide reductase in expression of the neoplastic program
  Life Sciences, 1981
• Enzymology of Cancer Cells
  New England Journal of Medicine, 1977
• Nicotinyl and Isonicotinyl Hydrazones of Pyridoxal
  Journal of the American Chemical Society, 1954